Annual CFO
-$32.61 M
+$7.98 M+19.67%
31 December 2023
Summary:
Werewolf Therapeutics annual cash flow from operations is currently -$32.61 million, with the most recent change of +$7.98 million (+19.67%) on 31 December 2023. During the last 3 years, it has risen by +$10.26 million (+23.94%). HOWL annual CFO is now -241.77% below its all-time high of -$9.54 million, reached on 31 December 2019.HOWL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$12.46 M
+$1.72 M+12.10%
30 September 2024
Summary:
Werewolf Therapeutics quarterly cash flow from operations is currently -$12.46 million, with the most recent change of +$1.72 million (+12.10%) on 30 September 2024. Over the past year, it has dropped by -$7.88 million (-171.80%). HOWL quarterly CFO is now -4012.87% below its all-time high of -$303.00 thousand, reached on 30 June 2022.HOWL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$46.52 M
-$5.25 M-12.73%
30 September 2024
Summary:
Werewolf Therapeutics TTM cash flow from operations is currently -$46.52 million, with the most recent change of -$5.25 million (-12.73%) on 30 September 2024. Over the past year, it has dropped by -$13.91 million (-42.65%). HOWL TTM CFO is now -1268.67% below its all-time high of -$3.40 million, reached on 31 March 2020.HOWL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HOWL Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -171.8% | -42.6% |
| 3 y3 years | +23.9% | +1.7% | -8.5% |
| 5 y5 years | -241.8% | - | - |
HOWL Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +23.9% | -4012.9% | +18.5% | -42.6% | +6.0% |
| 5 y | 5 years | -241.8% | +23.9% | -4012.9% | +18.5% | -1268.7% | +6.0% |
| alltime | all time | -241.8% | +23.9% | -4012.9% | +18.5% | -1268.7% | +6.0% |
Werewolf Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.46 M(-12.1%) | -$46.52 M(+12.7%) |
| June 2024 | - | -$14.18 M(-7.3%) | -$41.27 M(+8.6%) |
| Mar 2024 | - | -$15.30 M(+233.6%) | -$38.01 M(+16.6%) |
| Dec 2023 | -$32.61 M(-19.7%) | -$4.58 M(-36.4%) | -$32.61 M(-18.3%) |
| Sept 2023 | - | -$7.21 M(-34.0%) | -$39.90 M(-15.4%) |
| June 2023 | - | -$10.92 M(+10.3%) | -$47.16 M(+29.1%) |
| Mar 2023 | - | -$9.90 M(-16.6%) | -$36.54 M(-10.0%) |
| Dec 2022 | -$40.60 M | -$11.87 M(-18.0%) | -$40.60 M(-1.9%) |
| Sept 2022 | - | -$14.47 M(+4676.2%) | -$41.40 M(+5.2%) |
| June 2022 | - | -$303.00 K(-97.8%) | -$39.34 M(-20.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$13.95 M(+10.1%) | -$49.50 M(+15.5%) |
| Dec 2021 | -$42.88 M(+130.2%) | -$12.67 M(+2.1%) | -$42.88 M(+18.4%) |
| Sept 2021 | - | -$12.42 M(+18.7%) | -$36.21 M(+26.1%) |
| June 2021 | - | -$10.46 M(+42.8%) | -$28.72 M(+27.3%) |
| Mar 2021 | - | -$7.33 M(+21.9%) | -$22.55 M(+21.1%) |
| Dec 2020 | -$18.62 M(+95.2%) | -$6.01 M(+22.1%) | -$18.62 M(+47.6%) |
| Sept 2020 | - | -$4.92 M(+14.6%) | -$12.62 M(+64.0%) |
| June 2020 | - | -$4.29 M(+26.4%) | -$7.69 M(+126.4%) |
| Mar 2020 | - | -$3.40 M | -$3.40 M |
| Dec 2019 | -$9.54 M | - | - |
FAQ
- What is Werewolf Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Werewolf Therapeutics?
- What is Werewolf Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Werewolf Therapeutics?
- What is Werewolf Therapeutics quarterly CFO year-on-year change?
- What is Werewolf Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Werewolf Therapeutics?
- What is Werewolf Therapeutics TTM CFO year-on-year change?
What is Werewolf Therapeutics annual cash flow from operations?
The current annual CFO of HOWL is -$32.61 M
What is the all time high annual CFO for Werewolf Therapeutics?
Werewolf Therapeutics all-time high annual cash flow from operations is -$9.54 M
What is Werewolf Therapeutics quarterly cash flow from operations?
The current quarterly CFO of HOWL is -$12.46 M
What is the all time high quarterly CFO for Werewolf Therapeutics?
Werewolf Therapeutics all-time high quarterly cash flow from operations is -$303.00 K
What is Werewolf Therapeutics quarterly CFO year-on-year change?
Over the past year, HOWL quarterly cash flow from operations has changed by -$7.88 M (-171.80%)
What is Werewolf Therapeutics TTM cash flow from operations?
The current TTM CFO of HOWL is -$46.52 M
What is the all time high TTM CFO for Werewolf Therapeutics?
Werewolf Therapeutics all-time high TTM cash flow from operations is -$3.40 M
What is Werewolf Therapeutics TTM CFO year-on-year change?
Over the past year, HOWL TTM cash flow from operations has changed by -$13.91 M (-42.65%)